Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More screening to cut EU cancer deaths, says Italy:

This article was originally published in Clinica

Executive Summary

More screening is needed to further reduce cancer mortality, says the Italian health ministry in response to a study published recently on the evolution of cancer care across the EU. Some 92,750 cancer-related deaths were averted across the EU, between 1985-2000, 9% less than had been estimated. The target set in 1985 was to cut cancer mortality in 2000 by 15%. Italy - together with Luxembourg and the UK - fell short, with a 13% reduction. Austria and Finland met the target, while Portugal and Greece performed worst. "Screening, particularly of women, with Pap cervical smear testing and mammography, are key to further reducing cancer mortality," says the Italian health ministry.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063473

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel